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Caenorhabditis elegans TOM-1 is orthologous to vertebrate tomosyn, a cytosolic syntaxin-binding protein implicated in
the modulation of both constitutive and regulated exocytosis. To investigate how TOM-1 regulates exocytosis of
synaptic vesicles in vivo, we analyzed C. elegans tom-1 mutants. Our electrophysiological analysis indicates that
evoked postsynaptic responses at tom-1 mutant synapses are prolonged leading to a two-fold increase in total charge
transfer. The enhanced response in tom-1 mutants is not associated with any detectable changes in postsynaptic
response kinetics, neuronal outgrowth, or synaptogenesis. However, at the ultrastructural level, we observe a
concomitant increase in the number of plasma membrane-contacting vesicles in tom-1 mutant synapses, a phenotype
reversed by neuronal expression of TOM-1. Priming defective unc-13 mutants show a dramatic reduction in plasma
membrane-contacting vesicles, suggesting these vesicles largely represent the primed vesicle pool at the C. elegans
neuromuscular junction. Consistent with this conclusion, hyperosmotic responses in tom-1 mutants are enhanced,
indicating the primed vesicle pool is enhanced. Furthermore, the synaptic defects of unc-13 mutants are partially
suppressed in tom-1 unc-13 double mutants. These data indicate that in the intact nervous system, TOM-1 negatively
regulates synaptic vesicle priming.
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Introduction
Membrane fusion is mediated by the interactions of
cognate SNARE (soluble NSF attachment protein receptor)
proteins associated with vesicle and target membranes [1,2].
Synaptic vesicle exocytosis is a highly specialized form of
membrane fusion in which calcium triggers fusion of synaptic
vesicles with the plasma membrane, resulting in neuro-
transmitter release. Prior to vesicle fusion, the plasma
membrane Q-SNAREs syntaxin-1a and SNAP-25 assemble
with the vesicle-associated R-SNARE synaptobrevin-2 (a.k.a.
VAMP-2) to form a stable coiled-coil complex known as the
SNARE complex [3,4]. The assembly of the SNARE complex
in trans is thought to bring the vesicle into close apposition
with the plasma membrane, and may drive the fusion reaction
[5]. Several synaptic proteins have been implicated in the
regulation of this fusion process through their SNARE
interactions, including the recently identiﬁed protein tomo-
syn [6].
Tomosyn is a 130 kDa soluble protein ﬁrst isolated from rat
cerebral cytosol as a syntaxin-binding partner capable of
disrupting Munc18–syntaxin-1a complexes [6]. There are two
paralogous tomosyn genes in the mammalian genome
(tomosyn-1 and  2) that give rise to seven tomosyn isoforms
through differential splicing [7,8]. All mammalian tomosyn
isoforms have two recognizable domains, an N-terminal
domain rich in WD40 repeats and a C-terminal SNARE
domain with high sequence homology to the R-SNARE
domain of synaptobrevin [9,10]. WD40 repeats are known to
form beta propellers that act as protein interacting modules,
although binding partners of the tomosyn WD40 repeats have
yet to be identiﬁed. The tomosyn R-SNARE domain interacts
with syntaxin and SNAP-25 to form a tomosyn SNARE
complex that does not contain synaptobrevin but still binds
to the putative calcium sensor synaptotagmin [6]. The
biophysical properties of the tomosyn SNARE complex
resemble those of the SNARE complex: both form at similar
rates, have strong hysteresis during folding/unfolding tran-
sitions, exhibit alpha helicity, and are disassembled by NSF
[10]. Consistent with these properties, the crystal structure of
the core tomosyn SNARE complex reveals a four-alpha
helical arrangement between the SNARE domains of tomo-
syn, SNAP-25, and syntaxin that is similar to the structure of
the synaptobrevin-containing SNARE complex [11]. As
predicted from the similarity in crystal structures, synapto-
brevin is unable to displace tomosyn from the tomosyn
SNARE complex (and vice versa), without prior NSF
disassembly [11]. These data imply that formation of tomosyn
SNARE complexes may preclude synaptobrevin-containing
SNARE complex assembly, and therefore negatively regulate
vesicle exocytosis. Consistent with this model, overexpression
of vertebrate tomosyn reduces depolarization-induced dense-
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PLoS BIOLOGYcore granule fusion from PC12 cells [6,10], chromafﬁn cells
[12], insulin-mediated exocytosis of GLUT4-containing
vesicles from adipocytes [13], insulin release from beta cells
[14], and synaptic transmission in cultured superior cervical
ganglion neurons [15]. Although these data support a
negative regulatory role for tomosyn in vesicle fusion,
tomosyn RNA interference (RNAi) experiments have yielded
mixed results. In cultured superior cervical ganglion neurons,
tomosyn RNAi inhibited evoked release [15], whereas
tomosyn RNAi in mouse beta cells enhanced exocytosis [14].
To address the role of tomosyn in synaptic transmission, in
this study we directly assayed the physiological phenotype of
tomosyn loss-of-function mutants at the Caenorhabditis elegans
neuromuscular junction (NMJ). Our results indicate that
tomosyn inhibits synaptic transmission through actions that
regulate the size of the readily releasable vesicle pool.
Results
tom-1 Encodes the C. elegans Tomosyn Homolog
The C. elegans genome encodes a single tomosyn gene [16],
tom-1, that shares signiﬁcant identity (;33%) with isoforms of
mammalian tomosyn-1 and tomosyn-2 (Figure 1A). Like
vertebrate tomosyn, C. elegans tom-1 encodes multiple alter-
natively spliced isoforms, TOM-1(A,B,C) which share the C-
terminal coiled-coil motif resembling the R-SNARE domain
of C. elegans synaptobrevin (SNB-1) (Figure 1B). The TOM-1B
isoform is much smaller than either TOM-1A or TOM-1C,
and lacks the N-terminal WD40 repeats. To examine whether
the common C-terminal coiled-coil motif of TOM-1 (TOM-
1Ct) interacts with syntaxin and SNAP-25, we performed in
vitro pull-down assays using recombinant C. elegans proteins.
We compared the behavior of synaptobrevin and TOM-1Ct in
complex assembly assays with syntaxin-GST (UNC-64) [17]
and SNAP-25 (RIC-4) [18]. Both SNB-1 and TOM-1Ct formed
complexes, but did so inefﬁciently (Figure 1C). Systematic
replacement of each protein in the SNARE complex assay
revealed that all assays containing the C. elegans SNAP-25
formed inefﬁciently, while all other mixed species formed
complexes efﬁciently (Figure S1). When the TOM-1Ct was
mixed with C. elegans syntaxin-GST and vertebrate SNAP-25,
syntaxin-GST co-precipitated TOM-1Ct and SNAP-25 (Figure
1D). TOM-1Ct did not form a stable binary complex with
syntaxin (Figure S2). TOM-1Ct formed complexes as efﬁ-
ciently as SNB-1 forms complexes, but the TOM-1–containing
complex was SDS sensitive, while the SNB-1–containing
complex was SDS resistant. Density traces of the Coomassie
blue–stained protein incorporated into the mixed-species
TOM-1 complex gave densitometry ratios of 1:1.3:1.2 when
divided by the molecular mass for each of the fusion proteins
(Figure 1D), consistent with the 1:1:1 stoichiometry reported
for the vertebrate tomosyn complex [10]. These data conﬁrm
that C. elegans TOM-1 has the ability to form pseudo-SNARE
complexes similar to those of vertebrate tomosyn.
tom-1 Mutant Behavioral and Electrophysiological
Phenotypes
To investigate the function of TOM-1 in vivo, we
characterized the phenotypes of two previously isolated
tomosyn hypomorphic mutants, tom-1(ok285) and tom-
1(nu468), which disrupt both full-length TOM-1 isoforms
(TOM-1A/C) but are not predicted to disrupt the short TOM-
1B isoform (Figure 1A) [16]. These mutants are viable but
exhibit hypersensitivity to the acetycholinesterase inhibitor
aldicarb, suggesting that cholinergic neurotransmission is
enhanced either pre- or postsynaptically [16]. In several
behavioral assays tom-1 mutants exhibit mild defects, includ-
ing reduced brood size (331.5 6 7.2 progeny, n¼10, for wild-
type [WT] vs. 299.2 6 14.4 progeny, n¼9, for tom-1(ok285), p¼
0.055; and 206.6 6 11.8 progeny, n ¼ 9, for tom-1(nu468), p ,
0.0001), decreased thrashing rates in solution (121.7 6 1 body
bends/min, n¼10, for WT vs. 103.2 6 3.9 body bends/min, n¼
10, for tom-1(ok285), p ¼ 0.0002; and 92.3 6 2.4 body bends/
min, n ¼ 10, for tom-1(nu468), p , 0.0001), and altered
responses to head taps: speciﬁcally, tom-1 mutants exhibited
increased forward/backward reversals (1.3 6 0 .4 reversals, n¼
7, for WT vs. 4.9 6 1.5 reversals, n ¼ 7, for tom-1(ok285), p ¼
0.036; and 4.1 6 0.9 reversals, n ¼ 7, for tom-1(nu468), p ¼
0.011) and increased incidence of pauses (0 pauses, n ¼ 7, for
WT vs. 4.4 6 1.5 pauses, n ¼ 7, for tom-1(ok285); and 7.3 6 2.2
pauses, n ¼ 7, for tom-1(nu468)). tom-1 mutants were
indistinguishable from WT for other behaviors, such as
defecation cycle (intervals between expulsion events: 53.4 6
0.5 s, n ¼ 5, for WT vs. 53.2 6 2s ,n ¼ 5, for tom-1(ok285); and
52.8 6 1.3, n ¼ 6, for tom-1(nu468)). The aldicarb hyper-
sensitivity and behavioral changes of tom-1 mutants are
consistent with the hypothesis that TOM-1 function is
required for proper signaling between neurons.
To directly test whether mutations in tom-1 alter synaptic
transmission, we recorded synaptic responses from the NMJs
of dissected worms. Evoked responses were elicited by
applying a depolarizing stimulus to the ventral nerve cord
and recorded from voltage-clamped postsynaptic body wall
muscles. In 5 mM Ca
2þ saline the evoked current amplitudes
were not signiﬁcantly altered in tom-1 mutants (2,327 6 107
pA, n¼47, for WT vs. 2,443 6 136 pA, n¼37, for tom-1(ok285),
p¼0.5; and 2,560 6 283 pA, n¼11, for tom-1(nu468), p¼0.37)
(Figure 2A and 2B). However, the charge integral, a measure
of the total ion ﬂux during the evoked response (18.1 6 0.97
pC, n¼49, for WT vs. 38.2 6 2.7 pC, n¼30, for tom-1(ok285), p
, 0.0001; and 42.6 6 5.6 pC, n ¼ 8, tom-1(nu468), p , 0.0001)
(Figure 2B), was greatly increased in tom-1 mutants due to a
prolonged postsynaptic response (half-time–evoked decay:
4.6 6 0.17 ms, n ¼47, for WT vs. 12 6 1.1 ms, n ¼30, for tom-
1(ok285), p , 0.0001; and 12.3 6 1.7 ms, n¼8, for tom-1(nu468),
p , 0.0001) (Figure 2B). The enhanced evoked charge integral
of tom-1 mutants in the absence of an increase in evoked
amplitude could reﬂect saturation of the postsynaptic
receptor ﬁeld under the relatively high calcium (5 mM)
recording conditions used. To test this possibility, we
measured the evoked responses of tom-1 mutants in 0.5 mM
Ca
2þ. In lower calcium, the evoked response amplitudes of
tom-1 mutants were still comparable to the WT (1,100 6 108
pA, n¼13, for WT vs. 1,410 6 178 pA, n¼7, for tom-1(ok285), p
. 0.1; and 1,533 6 202 pA, n ¼ 8, for tom-1(nu468), p . 0.05);
however, the response duration remained signiﬁcantly
prolonged (half-time decay: 2.7 6 0.17 ms for WT vs. 4.2 6
0.57 ms for tom-1(ok285), p ¼ 0.016; and 4.2 6 .37 ms for tom-
1(nu468), p ¼ 0.0014), again resulting in increased charge
integrals (6.9 6 0.82 pC for WT vs. 10.7 6 1.2 pC for tom-
1(ok285), p ¼ 0.018; and 13.3 6 2 pC for tom-1(nu468), p ¼
0.006). These data suggest that the enhanced release observed
in tom-1 mutants is due primarily to a prolongation of the
evoked response.
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Tomosyn Inhibits Vesicle PrimingFigure 1. TOM-1 Is the C. elegans Tomosyn Homolog
(A) Gene structure of the three C. elegans TOM-1 isoforms. All isoforms were confirmed by expressed sequence tags 39 to the 6th exon and the upstream
59 region common to TOM-1A, and TOM-1C was determined by 59 RACE. The two long isoforms TOM-1A and TOM-1C contain N-terminal WD40 repeats
and a C-terminal SNARE domain. The short isoform (TOM-1B) contains only the SNARE domain. tom-1(nu468) is a G to A change in W212 resulting in an
early stop predicted to disrupt isoforms TOM-1A and TOM-1C [16]. The mutation in tom-1(ok285) is a 1,580-bp deletion that removes part of exon 10
and all of exons 11 through 13. tom-1(ok285) disrupts TOM-1A but, by RT-PCR can produce a mRNA capable of encoding an alternative isoform of TOM-
1C lacking exons 11–13 and containing a partial exon 10 and an extra eight amino acids.
(B) Amino acid alignment of the R-SNARE domain of rat tomosyn-1, mouse tomosyn-2, C. elegans TOM-1, and C. elegans synaptobrevin-1. Identity is
shown as black boxes and similarity as gray boxes. Numbers below indicate helical layers formed during SNARE complex assembly.
(C) TOM-1Ct forms tomosyn SNARE complexes with syntaxin and SNAP-25 in vitro to the same extent as C. elegans synaptobrevin (SNB-1) forms
synaptobrevin SNARE complexes. C. elegans syntaxin::GST, or GST alone was incubated with SNAP-25–His6 and either His6T7-tagged TOM-1Ct, or
His6T7-tagged SNB-1. Complexes were isolated using glutathione agarose beads. SDS resistance of complexes was assayed by heating half of the pull-
down before electrophoresis. Proteins were separated on SDS-PAGE and transferred to nitrocellulose and detected with anti-GST, anti-His6, and anti-T7
antibodies.
(D) Mixed-species tomosyn SNARE and synaptobrevin SNARE complexes form efficiently. Complexes were formed and isolated as described for (C)
except that rat SNAP-25 (vSNAP-25–His6) was used in place of the C. elegans protein. Complexes were visualized by Coomassie Blue staining after SDS-
PAGE. Complex stoichiometry of the tomosyn SNARE complex (*) was estimated by densitometry shown on left. The integrated density of each peak is
listed. The molecular weight markers are (from top to bottom) 97 kDa, 66 kDa, 45 kDa, 31 kDa, 21 kDa, and 14 kDa.
DOI: 10.1371/journal.pbio.0040261.g001
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Tomosyn Inhibits Vesicle PrimingSince evoked responses under our recording conditions
largely reﬂect cholinergic transmission, we next asked
whether the prolonged evoked response of tom-1 mutants
could be rescued by expressing TOM-1 protein speciﬁcally in
cholinergic neurons. Recordings from tom-1(nu468) mutants
possessing an integrated TOM-1A cDNA array (jaIs1052)
reduced the excitatory postsynaptic current amplitude when
compared to both WT or tom-1(nu468) (1,094 6 105 pA, n¼8,
for jaIs1052, p   0.0006, relative to tom-1(nu468)) and reversed
the increased response duration to WT levels (4.7 6 0.74 ms,
n ¼ 7, for jaIs1052, p ¼ 0.0019, relative to tom-1(nu468)),
resulting in a signiﬁcant decrease in total charge integral (9.2
6 1.3 pC, n ¼ 7) relative to both WT (p ¼ 0.0001) and tom-
1(nu468) (p , 0.0001) (Figure 2A and 2B). We attribute the
decrease in release in jaIs1052 relative to WT to over-
expression of TOM-1A based on real-time PCR measure-
ments of mRNA levels that indicate tom-1A mRNA levels are
11 6 1.3 (n ¼ 3) times that of the WT. Together, these data
suggest that TOM-1A is required presynaptically to regulate
synaptic transmission. This observation is consistent with the
neuron-speciﬁc expression pattern of TOM-1 based on a tom-
1 promoter::GFP fusion construct [16].
Although the TOM-1A expression experiments indicate
that enhanced release in tom-1 mutants has a presynaptic
origin, the prolonged duration of the evoked response in tom-
1 mutants could be due to altered postsynaptic receptor
kinetics. We therefore examined the electrophysiological
properties of miniature postsynaptic events (Figure 2C and
2D). Neither the decay rates (decay half-width: 2.05 6 0.05 ms,
n¼57, for WT vs. 2.03 6 0.07 ms, n¼25, for tom-1(ok285), p .
0.5; and 2.12 6 0.12 ms, n ¼ 15, for tom-1(nu468), p . 0.8), the
amplitude (24.7 6 0.8 pA, n¼57, for WT vs. 22.4 6 0.8 pA, n¼
25, for tom-1(ok285), p¼0.1; and 26.8 6 2.3 pA, n¼16, for tom-
1(nu468), p ¼ 0.28), nor the frequency (94.3 6 6.6 Hz, n ¼ 57,
for WT vs. 88.4 6 8.9 Hz, n¼26, for tom-1(ok285), p¼0.6; and
10.3 6 13.5 Hz, n ¼ 16, for tom-1(nu468), p ¼ 0.6) (Figure 2C
and 2D) of miniature synaptic events in tom-1 mutants were
signiﬁcantly different from the WT. These results suggest that
the tom-1 mutant synaptic phenotype is not due to changes in
postsynaptic reception. Consistent with this conclusion, the
miniature postsynaptic response kinetics of the neuronal
TOM-1A–expressing integrants (jaIs1052) (decay: 2.46 6 0.2
ms, n ¼ 7, p ¼ 0.14; minifrequency: 84.8 6 12.7 Hz, n ¼ 8, p ¼
0.45) were not signiﬁcantly different from tom-1(nu468) alone,
despite the rescue of the evoked response duration and
charge integral (Figure 2C and 2D).
Neuronal Architecture of tom-1 Mutants
Vertebrate tomosyn has been implicated in the regulation
of neurite outgrowth in mammalian cultured neurons [19].
Therefore, we next addressed whether the enhanced evoked
release in C. elegans tom-1 mutants could be due to aberrant
neuronal connectivity. To examine the neuronal cytoarchi-
tecture of tom-1 mutants, we crossed in an integrated array
(juIs14) expressing cytoplasmic green ﬂuorescent protein
(GFP) under the cholinergic neuron speciﬁc promoter Pacr-
2 [20]. Analysis of axonal left/right orientation, axon target-
ing, and axon fasciculation revealed no differences in the
neuronal morphology of tom-1(ok285);juIs14 relative to the
WT (Figure 3A and 3B), suggesting that the tom-1 phenotype is
not associated with any discernable innervation defects.
To test for possible changes in synaptogenesis, we
examined the number and distribution of neuromuscular
synapses in tom-1 mutants. C. elegans neuromuscular synapses,
which form en passant along the ventral nerve cord onto
body wall muscles, can be visualized using pre- and
postsynaptic markers. Speciﬁcally, synapses in WT and tom-1
mutant animals were immunolabeled with antibodies to the
presynaptic vesicular ACh transporter, UNC-17 [21] (Figure
3C), and UNC-29, a postsynaptic muscle ACh receptor
subunit (Figure 3D). Analysis of the staining revealed that
the number of synapses based on presynaptic staining (3.13 6
0.1 UNC-17 puncta/10 lm, n ¼ 5, for tom-1(nu468) vs. 3.6 6
0.27 puncta/10 lm, n ¼ 5, for WT, p ¼ 0.14) and postsynaptic
staining (2.89 6 0.20 UNC-29 puncta/10 lm, n ¼ 9, for tom-
1(nu468) vs. 3.08 6 0.24 puncta/10 lm, n¼10, for WT, p . 0.5)
was not signiﬁcantly altered. Similarly, the size of presynaptic
puncta (1.55 6 0.06 lm, n ¼ 5, for tom-1(nu468) vs. 1.5 6 0.1
lm, n ¼ 5, for WT, p ¼ 0.69) and postsynaptic puncta (1.61 6
0.08 lm, n ¼ 5, for tom-1(nu468) vs. 1.74 6 0.07 lm, n ¼ 5, for
WT, p ¼ 0.19) were not signiﬁcantly affected in tom-1(nu468).
The reduction in evoked response in the TOM-1A–expressing
strain (jaIs1052) could also not be attributed to discernable
changes in the number or size of cholinergic neuromuscular
Figure 2. Electrophysiological Phenotypes of tom-1 Mutants
(A) Electrophysiological recordings from NMJs of dissected worms,
revealed a pronounced increase in evoked response duration in both
tom-1 mutant alleles (ok285 and nu468) that is reversed in jaIs1052,
expressing TOM-1A in cholinergic neurons of tom-1(nu468).
(B) Analysis of evoked responses detected as inward currents from
voltage-clamped body wall muscles in response to 2 ms depolarizing
ventral cord stimuli. Evoked amplitude (pA) is normal in tom-1 mutants
and decreased in jaIs1052 (left). Half-time–evoked response decay (ms) is
increased in tom-1 mutants and restored to normal levels in jaIs1052
(middle). Total charge integral is increased in tom-1 mutants and reduced
in jaLs1052 (right).
(C) Representative endogenous miniature postsynaptic events.
(D) Event amplitude (left), frequency (middle), and decay rates (right)
were normal in tom-1 mutants and jaIs1052.. Data expressed as mean 6
SEM.
DOI: 10.1371/journal.pbio.0040261.g002
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phenotype is not associated with any overt defects in
morphogenesis of the nervous system and might therefore
reﬂect a speciﬁc defect in synaptic function.
Ultrastructural Analysis of tom-1 Mutants
To test whether the enhanced release in tom-1 mutants
resulted from increased synaptic vesicle biogenesis or altered
vesicle distribution within synapses, we examined synaptic
ultrastructure by electron microscopy (EM) (Figure 4). Recent
advances in high-pressure freeze and freeze substitution
ﬁxation techniques to prepare worms for EM have greatly
improved the quality of ultrastructural data obtained in C.
elegans [22]. The advantage of this technique over conven-
tional ﬁxation is that by virtue of the instantaneous freezing
of the worms and gradual substitution with ﬁxative, there is
less ﬁxation-induced osmotic shock that normally results in
cell shrinkage and possible redistribution of synaptic vesicles
to the plasma membrane. Using this technique, we found that
while the average number of vesicles per synaptic proﬁle did
not differ from the WT in tom-1(ok285) mutants (17.45 6 0.86
vesicles/proﬁle, n ¼ 86 proﬁles, for WT vs. 17 6 0.81 vesicles/
proﬁle, n ¼ 74 proﬁles, for tom-1(ok285)), vesicle localization
was affected. Speciﬁcally, tom-1(k285) mutants exhibited a
dramatic and signiﬁcant (p , 0.0001) increase in the number
of vesicles contacting the plasma membrane (15.6% 6 0.75%,
n¼74 synaptic proﬁles, for tom-1(ok285) vs. 8.5% 6 0.3%, n¼
250 synaptic proﬁles, for WT) (Figure 4A and 4B). In WT
synapses, contacting vesicles were preferentially localized
within ;150 nm of the presynaptic density (Figure 4C and
4D), whereas in tom-1(ok285) mutants the increase in
membrane-contacting vesicles were distributed throughout
the terminal (Figure 4C and 4D).
We next examined the ultrastructure of jaIs1052 (Figure 5).
Since TOM-1A expression was restricted to the cholinergic
motor neurons of tom-1(nu468) mutants in jaIs1052, we
compared the contacting vesicle pool of cholinergic synapses
in jaIs1052 versus tom-1(nu468) mutants (Figure 5A and 5B).
Consistent with the reduced evoked response, cholinergic
synapses in jaIs1052 had fewer contacting vesicles relative to
tom-1(nu468) (7.9% 6 0.4% , n ¼ 56 proﬁles, for jaIs1052 vs.
15.8% 6 0.6 %, n ¼ 49 proﬁles, for tom-1(nu468), p , 0.0001)
(Figure 5B). As an internal control for the speciﬁcity of the
TOM-1A rescue, we also examined the number of contacting
vesicles in the GABAergic synapses of jaIs1052 worms (Figure
5D and 5E). The number of contacting vesicles was not
signiﬁcantly different (p . 0.5) between jaIs1052 GABA
synapses (11.4% 6 1%, n ¼ 20) and tom-1(nu468) (13.7% 6
0.8 %, n¼19 proﬁles) (Figure 5E). Similarly, the distribution of
vesicles in cholinergic synapses was reduced throughout the
terminal in jaIs1052 cholinergic synapses (Figure 5C), but not
in the GABAergic synapses of the same worms (Figure 5F).
These data establish that vesicle contact is regulated by TOM-
1 in both cholinergic and GABAergic synapses in C. elegans.
Figure 3. The Number and Distribution of NMJ Synapses in WT, tom-
1(nu468)–, and TOM-1A–Expressing Animals
(A) A schematic representation of the cholinergic motorneurons, and the
outgrowth patterns of the dorsal neurons (inset).
(B) The cholinergic motorneurons in tom-1 (ok285) animals (left) do not
show any obvious changes from the wild type (right).
(C) Representative images of the ventral nerve cord from WT, tom-
1(nu468), and tom-1(nu468) mutants expressing TOM-1A (jaIs1052),
immunolabeled with antibodies to the presynaptic marker, UNC-17
(vesicular ACh transporter).
(D) UNC-17 punctum size (left) and the number of puncta per 10 lm
(right) are normal in tom-1 mutants and jaIs1052.
(E) Representative images of the ventral nerve cord from WT, tom-
1(nu468), and jaIs1052 immunolabeled with antibodies to the post-
synaptic marker, UNC-29 (ACh receptor). Scale bar ¼ 10 micrometers
(D) UNC-29 punctum size (lm) and the number of puncta per 10 lm are
normal in tom-1 mutants and jaIs1052.
Data in (C) and (D) expressed as mean 6 SEM.
DOI: 10.1371/journal.pbio.0040261.g003
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Since the formation of tomosyn SNARE complexes com-
petes with the assembly of synaptobrevin-containing SNARE
complexes, it has been proposed that tomosyn may inhibit
synaptic vesicle priming. Therefore, the enhanced release and
increased contacting vesicle pool in tom-1 mutants could
reﬂect an increase in the size of the readily releasable pool.
To directly measure the size of the readily releasable pool in
tom-1 mutants, we recorded hyperosmotic responses at the
neuromuscular junction. The hyperosmotic responses of both
tom-1 alleles were signiﬁcantly increased relative to the WT
(18.4 6 2.8 pC, n¼13, for WT vs. 34.6 6 5.1 pC, n¼6, for tom-
1(n468), p¼0.0125; and 28.8 6 4.8 pC, n¼10 for tom-1(ok285),
p ¼ 0.049) (Figure 6), indicating that loss of TOM-1 results in
an increased primed vesicle pool.
If the increased plasma membrane-contacting vesicle pool
in tom-1 mutants were a reﬂection of enhanced priming, we
would predict that the priming-defective mutant unc-13(s69)
would have fewer contacting vesicles. Morphometric analysis
of unc-13 mutants revealed a profound reduction in mem-
brane-contacting vesicles relative to the WT (3.5% 6 0.3%, n
¼ 101 synaptic proﬁles, for unc-13(s69) vs. 8.5% 6 0.3%, n ¼
250 synaptic proﬁles, for WT, p , 0.0001) (Figure 6A and 6B).
This reduction is consistent with the proposed role of UNC-
13 in promoting SNARE complex formation and thus, vesicle
apposition with the plasma membrane.
Our analysis of tom-1 mutants suggests that priming is
upregulated in the absence of TOM-1. Therefore, we next
asked whether tom-1 mutants could suppress the synaptic
defects associated with unc-13 mutants. In tom-1(ok285) unc-
13(s69) double mutants the number of contacting vesicles
relative to unc-13(s69) increased to 5.9% 6 0.2% per proﬁle (n
¼ 124 synaptic proﬁles, p , 0.0001) (Figure 6A and 6B). The
distribution of contacting vesicles relative to the presynaptic
density increased throughout the terminal in the tom-1(ok285)
unc-13(s69) double mutants (Figure 6C). Coincident with this
morphological rescue, tom-1(ok285) unc-13(s69) double mu-
tants exhibited increased aldicarb sensitivity relative to unc-
13(s69) mutants, indicating that ACh release was partially
restored (unpublished data). Recordings from the NMJ
conﬁrmed that both the evoked amplitude (3.3 6 3.3 pA, n
¼ 6, for unc-13(s69) vs. 752 6 121 pA, n ¼ 12, for tom-1(ok285)
unc-13(s69), p , 0.0006), and total charge integral (0.11 6 0.05
pC, n ¼ 6, for unc-13(s69) vs. 6 6 1.2 pC, n ¼ 11, for tom-
1(ok285) unc-13(s69), p , 0.0001) were increased in the double
mutants with decay time constants similar to those of the WT
Figure 4. tom-1(ok285) Mutants Accumulate Vesicles That Are Contacting the Plasma Membrane
(A) Examples of synaptic profiles from WT and tom-1(ok285) neuromuscular synapse prepared by high-pressure freeze and freeze substitution. The
presynaptic density is labeled PD, and the plasma membrane-contacting vesicles are indicated with arrows. Scale bar, 100 nm.
(B) Vesicles contacting the plasma membrane as a ratio of total vesicles per synaptic profile are increased in tom-1(ok285) mutant animals.
(C) The distribution of plasma membrane-contacting vesicles relative to the presynaptic density, expressed in 30-nm bins as a ratio of total vesicles per
profile for WT and tom-1(ok285).
(D) Schematic representation of data in (C) depicting the distribution of vesicles contacting plasma membrane (black circles for WT, purple circles for
tom-1 mutants) relative to the presynaptic density. Data expressed as mean 6 SEM.
DOI: 10.1371/journal.pbio.0040261.g004
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ms, n ¼ 47, for WT, p . 0.5) (Figure 6D). The recovery of
synaptic function in tom-1(ok285) unc-13(s69) mutants was
accompanied by a corresponding increase in the size of the
hyperosmotic response (5.3 6 0.34 pC, n ¼ 3, for tom-1(ok285)
unc-13(s69), vs. 1.17 6 0.51 pC, n¼6, for unc-13(s69), p¼0.001)
to 30% of the WT (17.4 6 3.3 pC, n¼11, for WT) (Figure 6E).
Together, these data suggest that the priming defect of unc-13
mutants can be partially ameliorated by removing TOM-1,
further supporting the conclusion that TOM-1 functions to
negatively regulate priming.
Discussion
Summary
We have examined the role of tomosyn in regulated
synaptic transmission by analyzing two hypomorphic mutants
of the C. elegans tomosyn homolog, tom-1 [16]. Our results
demonstrate that loss of TOM-1A and C isoforms enhances
evoked release at the neuromuscular junction. In the absence
of a complete tom-1 null, the role of the remaining isoform,
TOM-1B, remains to be elucidated. These results are
consistent with a previously reported increase in sensitivity
of tom-1 mutants to the toxic effects of the acetylcholine
esterase inhibitor, aldicarb, which is indicative of increased
cholinergic transmission [16]. The enhanced neurotransmis-
sion observed electrophysiologically correlates with a redis-
tribution of synaptic vesicles to the plasma membrane in tom-
1 mutant synapses. We further demonstrate that the ability of
synaptic vesicles to contact the plasma membrane is regulated
by the priming factor, UNC-13. When we generated tom-1 unc-
13 double mutants we observed partial suppression of the
unc-13 priming defect and concomitant restoration of the
plasma membrane-contacting vesicle pool. Consistent with
Figure 5. Comparison of the Plasma Membrane-Contacting Vesicles and Synaptic Vesicle Distribution in Cholinergic and GABAergic Synapses of WT,
tom-1(nu468), and TOM-1A–Expressing Animals (jaIs1052)
(A) Representative images of cholinergic synapses in tom-1(nu468) (top) and jaIs52 (bottom), Scale bar ¼ 200 nm.
(B) The ratio of the plasma membrane-contacting vesicles per profile is reduced in tom-1(nu468) mutants expressing TOM-1A in cholinergic neurons
(jaIs1052) compared to both tom-1(nu468) mutants and WT.
(C) The distribution of plasma membrane-contacting vesicles relative to the presynaptic density in cholinergic synapses of jaIs1052 and tom-1(nu468)
animals, expressed in 30-nm bins as ratio of total vesicles per profile.
(D) Representative images of a GABAergic synapse in tom-1(nu468) mutants (top) and jaIs1052 (bottom).
(E) The ratio of plasma membrane-contacting vesicles is significantly increased in tom-1(nu468) GABAergic synapses compared to WT, and is not rescued
by expressing TOM-1A in cholinergic neurons.
(F) The distribution of plasma membrane-contacting vesicles relative to the PD are similar in tom-1(nu468) and jaIs1052 animals at GABAergic
neuromuscular synapses. Data expressed as mean 6 SEM.
DOI: 10.1371/journal.pbio.0040261.g005
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insulin release [14], these data suggest that tomosyn acts as a
negative regulator of synaptic vesicle priming.
What Is the Molecular Mechanism by which Tomosyn
Negatively Regulates Vesicle Priming?
Priming is thought to involve formation of SNARE
complexes between synaptobrevin, syntaxin, and SNAP-25,
which bring the vesicle membrane into close apposition with
the plasma membrane [5,23]. Like vertebrate tomosyn [10], we
demonstrate that the C-terminal of C. elegans TOM-1 also has
the ability to form a complex with the SNARE domains of
syntaxin and SNAP-25, suggesting this is a conserved tomosyn
interaction. Vertebrate tomosyn competes with synaptobre-
vin for binding to syntaxin and SNAP-25 on the cytosolic
surface of PC12 cell membrane sheets [10] as well as in in
vitro biochemical studies [6]. By precluding vesicle-associated
synaptobrevin from assembly into SNARE complexes, tomo-
syn is thus proposed to limit vesicle priming. This model is
supported by several studies in which tomosyn overexpres-
sion has been shown to inhibit dense-core granule fusion
[6,10,12] and neuronal exocyto s i s[ 1 5 ] .F u r t h e r m o r e ,i n
Figure 6. tom-1(ok285) Suppresses the Synaptic Defects of unc-13(s69) Mutants
(A) Representative images of unc-13(s69) and tom-1(ok285)unc13(s69). (B) The ratio of plasma membrane-contacting vesicles per profile for WT (black),
unc-13(s69) (red), tom-1(ok285)unc13(s69) (maroon), and tom-1(ok285) (purple) scale bar¼200 nm. (C) Comparison of unc-13(s69) and tom-1(ok285)unc-
13(s69) plasma membrane-contacting vesicle distribution relative to the PD in 30-nm bins. (D) Representative NMJ recordings demonstrate that the
evoked response absent in unc-13(s69) mutants is partially restored in tom-1(ok285)unc13(s69) double mutants. The average evoked charge integral of
the tom1 unc-13 double mutants is graphed relative to WT and tom-1(ok285) mutant responses. (E) Representative recordings of hyperosmotic
responses demonstrate that the readily releasable pool of vesicles is increased in tom-1(ok285) relative to WT. The hyperosmotic response absent in unc-
13(s69) mutants is also partially restored in tom-1(ok285)unc13(s69) double mutants. The mean total charge integral for synaptic events in the first
second of the hyperosmotic response is graphed. Data expressed as mean 6 SEM.
DOI: 10.1371/journal.pbio.0040261.g006
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the fast exocytotic burst corresponding to the fusion-
competent primed granule pool [12]. In contrast to over-
expression data, RNAi–mediated knockdown of tomosyn has
produced mixed results. In cultured neurons tomosyn RNAi
causes a reduction in synaptic vesicle release [15], where as
RNAi in beta cells results in enhanced exocytosis [14]. This
former study follows a previous report indicating that
tomosyn RNAi profoundly inhibits directed neurite out-
growth, which could affect synaptogenesis under these
culture conditions, resulting in fewer functional synapses
[19]. In the context of an intact animal examined here, loss of
tomosyn function does not appear to be deleterious for
neurite outgrowth and synaptogenesis. Therefore, the en-
hanced neurotransmission we observe in C. elegans tom-1
mutants is more consistent with RNAi in beta cells and
appears to be attributable to functional changes in release
properties rather than aberrant neuronal cytoarchitecture.
Speciﬁcally, phenotypic analysis of C. elegans tom-1 mutants
supports the hypothesis that tomosyn acts as a negative
regulator of synaptic vesicle priming in vivo.
In contrast to the C. elegans tom-1 mutant ultrastructural
phenotype, tomosyn overexpression in chromafﬁn cells was
not associated with any changes in granule distribution based
on conventional EM [12]. In TOM-1A–overexpressing synap-
ses, we also observe near-normal numbers of contacting
vesicles. Therefore, there is no conﬂict between the ultra-
structural data reported for tomosyn overexpression and that
of the present study. However, it remains to be seen whether
loss of tomosyn in chromafﬁn cells is associated with
increased granule association with the plasma membrane.
Why Does tom-1(ok285) Suppress the Synaptic Defect of
unc-13(s69)?
UNC-13 is a member of a conserved family of synaptic
proteins implicated in vesicle priming [24–26]. The mamma-
lian homolog Munc13–1 is thought to interact with the N-
terminus of syntaxin [27]. Syntaxin can adopt a closed state in
solution that occludes the syntaxin SNARE domain (the H3
domain) required for SNARE complex formation [28]. UNC-
13 binding to the N-terminus of syntaxin has been proposed
to stabilize the syntaxin open conﬁguration, increasing
accessibility of the H3 domain [27]. Partial suppression of
the C. elegans unc-13 priming defect by overexpression of a
constitutively open form of syntaxin supports this model [29].
Furthermore, mutations that disrupt UNC-13/syntaxin inter-
actions in vitro have been shown to reduce release in both C.
elegans and chromafﬁn cells [30,31]. However, a Munc13
domain capable of partially rescuing priming in Munc13 KO
mice, fails to bind syntaxin [32], suggesting alternative
molecular mechanisms could also account for the priming
function of Munc13. Here we show that tom-1(ok285) can also
partially suppress the unc-13(s69) mutant phenotype. We
postulate that in unc-13 mutants, any transitions of syntaxin
to the open state are prevented from forming functional
SNARE complexes through the binding of tomosyn. It is also
possible that the presence of UNC-13 normally excludes
tomosyn from interacting with syntaxin and SNAP-25. In
either case, we propose that in tom-1 unc-13 double mutants,
syntaxin has an increased probability of assembling into
SNARE complexes because tomosyn no longer precludes
synaptobrevin binding to the plasma membrane SNAREs.
Why Is the Postsynaptic Response Prolonged in C. elegans
tom-1 Mutants?
Many of the contacting synaptic vesicles in tom-1(ok285)
mutants are found distal to the presynaptic specialization.
If, as at vertebrate NMJs [33], calcium channels are localized
to the presynaptic specialization in C. elegans, calcium-
triggered fusion of distal vesicles may be delayed relative to
the proximal vesicles, resulting in a prolonged muscle
response. It is also possible that the increased distance
between distal neurotransmitter release sites and postsy-
naptic receptors prolongs the postsynaptic response in tom-1
mutant muscles.
How Might Tomosyn Restrict the Membrane Localization
of Synaptic Vesicles?
One mechanism by which tomosyn may restrict synaptic
vesicle fusion has recently emerged from the study of
neurite outgrowth following tomosyn RNAi [19]. In cultured
hippocampal neurons, knockdown of tomosyn increases
neurite sprouting and branching while reducing neurite
extension. This regulation is proposed to involve a high-
afﬁnity interaction between tomosyn and phosphorylated
syntaxin (Ser14), which colocalize to the palms of growth
cones [19]. The phosphorylation of syntaxin (Ser14p) by
serine/threonine kinase (ROCK) leads to a ﬁve-fold increase
in binding of tomosyn relative to synaptobrevin. Synapto-
brevin-associated vesicles are thus predicted to be excluded
from priming in growth cone palms, fusing instead at the
leading edge of the growth cone, promoting neurite
extension. Whether a similar mechanism functions to
spatially restrict synaptic vesicle fusion to the active zone
region in synaptic terminals remains to be investigated.
However, syntaxin Ser14p is found throughout the rat
cortex and appears to be excluded from regions rich in
synaptic vesicles [34]. Therefore, it seems entirely possible
that tomosyn may act to restrict exocytosis at synaptic
terminals. Since syntaxin can be phosphorylated at Ser14 by
both ROCK [19] and casein kinase II [34], this could also
present a possible mechanism to regulate synaptic efﬁcacy
by affecting the level of tomosyn-mediated inhibition of
vesicle priming.
The interaction between tomosyn and syntaxin is also
regulated by protein kinase A–dependent phosphorylation of
tomosyn in the variable linker between the WD40 domain
and the C-terminal SNARE homology domain. Speciﬁcally,
phosphorylation of tomosyn reduces the binding afﬁnity of
the tomosyn–syntaxin interaction [15]. Furthermore, protein
kinase A–dependent synaptic facilitation appears to act in
part through the phosphorylation of tomosyn, suggesting
again that the interaction between tomosyn and syntaxin
negatively regulates neurotransmitter release.
In summary, tomosyn interacts with syntaxin and SNAP-25
to form tomosyn SNARE complexes predicted to be non-
fusogenic, which compete with SNARE complex formation
and thus inhibit vesicle priming. Tomosyn perturbation
analysis in C. elegans provides the ﬁrst in vivo evidence in
support of this model. Tomosyn mutants not only exhibit
enhanced release but also suppress the priming defects of unc-
13 mutants. Future studies can now address whether the
regulation of tomosyn function by kinases provide mecha-
nisms for synaptic plasticity.
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Genetics. Nematodes were maintained on agar plates seeded with
OP50 bacteria. Strains used were N2 Bristol, VC223 tom-1(ok285),
BC168 unc-13(s69), SY1020 tom-1(ok285)unc-13(s69), SY1016 tom-
1(ok285);oxIs12, KP 3293 tom-1(nu468), and SY1181 tom-1(nu468);-
jaIs1052 (integrated Punc17::tom1A).
In vitro biochemistry. Puriﬁcation of recombinant proteins
SNAREs lacking TM domains. Vectors for C. elegans SNAP-25 and
syntaxin were constructed as follows: the entire SNAP-25 coding
regionwas insertedinto pHO4d[35], thesyntaxincytoplasmic domain
(aa 1–266) was cloned into pGEX-2T, and the SNB-1 cytoplasmic
domain(aa 1–88) was cloned into pRSETC. The TOM-1 SNAREmotif–
coding region (TOM-1Ct; aa 1,137–1,211) was subcloned into pRSETC
and puriﬁed as an N-terminally his6-tagged protein. Rat SNAP-25-
His6 puriﬁed as described in [5] was provided by Phyllis Hanson
(Washington University School of Medicine, Saint Louis, Missouri,
United States). Proteins were puriﬁed using Ni-NTA resin or
glutathione agarose, followed in some cases by further puriﬁcation
on a Mono S column using fast protein liquid chromatography.
Methodology. Fusion proteins were batch-puriﬁed on Ni-NTA–
agarose according to the manufacturer’s protocols (Qiagen, Valencia,
California, United States) under native conditions with modiﬁed
buffers. The lysis buffer consisted of 20 mM HEPES (pH 7.4), 500 mM
KCl,0.1mMPMSF,0.1%ßME,5%glycerol;and0–5mMimidazole.The
wash and elution buffer consisted of 20 mM HEPES (pH 7.9), 200 mM
KCl, 0.1 mM PMSF,0.1%ßME, 5% glycerol, 0.5% TritonX-100, and 1–
300 mM imidazole. The dialysis buffer consisted of 10 mM HEPES (pH
7.9), 140 mM KCl, and 0.5% Triton X-100. The syntaxin-GST fusion
protein and GST alone were batch-puriﬁed with glutathione agarose
undernativeconditions[36].Thebuffersuseddifferedfromthoseused
in the Ni-NTA–agarose puriﬁcations only as follows: the lysis buffer
contained no imidazole and 100 mM EDTA; the wash and elution
buffer contained no imidazole, 2 mM EDTA, and 15 mM reduced
glutathione.ThepurityofthefractionswasveriﬁedbySDS-PAGE,and
the concentration was determined by the Bradford assay.
TOM-1 complex formation assays. For in vitro complex formation,
;1.6 lM of each of C. elegans syntaxin–GST (or GST), rat SNAP-25-
His6, and C. elegans His6-TOM-1Ct (or -His6-SNB-1) were incubated
from 2 h to overnight at 4 8C with rocking in D-buffer. The proteins
were added to an aliquot of pre-equilibrated glutathione-agarose
slurry and incubated at 4 8C for 1 h with rocking. The matrix was
washed four times with 400 ll D-buffer. SDS–sample buffer was
added, and half the reaction was heated (95 8C for 2 min) before
analysis on SDS-PAGE. Proteins were detected by Coomassie Blue
staining. D-buffer consisted of 10 mM HEPES (pH 7.9), 140 mM KCl,
0.5% Triton X-100, and 0.1 mM PMSF. Integrated densities were
calculated using ImageJ (rsb.info.nih.gov/ij/). Complexes assembled
using C. elegans SNAP-25-His6 were performed similarly, but after
transfer to nitrocellulose, proteins were detected by immunoblotting
using anti-GST, anti-His6 (SNAP-25, TOM-1Ct, and SNB-1), and anti-
T7 (TOM-1Ct and SNB-1) antibodies.
Behavioral assays. Thrashing assays in M9 solution were performed
by quantifying the number of bodybends/min.Forhead tap responses,
worms were allowed a 1-min settling period after placement in the
assay chamber with food, before recording responses to a head tap for
20 s. Brood size was quantiﬁed by plating ten L4 hermaphrodites of
each genotype onto individual plates and counting the number of
progeny by removing hatched larvae and embryos for 3–4 d.
Defecation rate was scored under a dissecting microscope using ten
young adult worms for each genotype. For each worm, the duration of
three consecutive defecations was measured and averaged. The cycle
was deﬁned as an interval between two expulsions of the gut content
after visible contraction of the body wall muscles.
Real-time PCR. C. elegans total RNA was isolated using a Trizol
reagent as described by the manufacturer (Invitrogen, Carlsbad,
California, United States). Total RNA (0.5 lg) was used for reverse
transcription using the SuperScript III First Strand Synthesis Kit
(Invitrogen). Absence of genomic DNA was conﬁrmed by PCR with
primers designed to amplify the GFP coding region. GFP is a high
copy coinjection marker, and we did not detect any genomic DNA
contamination. For ampliﬁcation of tomosyn isoform A, PCR primers
were designed to amplify a unique exon. Dynamin was used as a
reference for calibration. Real-time PCR was then performed by
ﬂuorescent detection and quantiﬁcation of SYBR green-labeled PCR
product using MJ Research Opticon2 real-time thermocycler (Bio-
Rad, Hercules, California, United States). For quantiﬁcation of
relative initial transcript levels, the cycle threshold (Ct) values for
isoform A and a dynamin control were determined for each sample.
The amount of tom-1A mRNA is reported as a ratio relative to the
calibrator (dynamin). After RT-PCR, the products were subjected to
agarose gel electrophoresis and sequencing to conﬁrm the speciﬁcity
of ampliﬁed products.
Immunohistochemistry. Immunohistochemistry was performed
using a modiﬁed method of the whole worm ﬁxation [37]. Brieﬂy,
the worms were frozen on dry ice between two slides, which were then
split apart. Frozen animals were ﬁxed in 4% slushy formaldehyde in
PBS. Following ﬁxation, animals were spun down at 1,600 rpm.
Antibodies against UNC-29 (kindly provided by Dr. K. G. Miller) and
UNC-17 (kindly provided by Dr. J. B. Rand) were used at a ﬁnal
dilution of 1:200 in PBS and 0.5% Triton X-100 with 3% BSA. Anti-
rabbit and anti-mouse TRITC-conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories, West Grove, Pennsylvania,
United States) were used at a 1:500 dilution for 4 h at 4 8C. Images
were obtained with a 603objective using an Olympus Optical (Tokyo,
Japan) FV-500 laser-scanning confocal microscope. Puncta size and
quantity were quantiﬁed from image projections of the ventral nerve
cord region upstream of the vulva using ImageJ.
Generation of TOM-1A rescuing lines. jaIs1052 strains expressing
an integrated array of TOM-1A in tom-1(nu468) mutants were
generated by irradiating animals expressing an extrachromasomal
array of TOM-1A cDNA and a Pmyo-2::gfp coinjection marker under
the cholinergic neuronal unc-17 promoter (kindly provided by Dr. J.
Kaplan) using a Cs source (total dose of 1,800 rad).
Electrophysiology. Electrophysiological methods were as previ-
ously described [25]. Brieﬂy, animals were immobilized with
cyanoacrylic glue, and a lateral cuticle incision was made exposing
the ventral medial body wall muscles. Muscle recordings were made in
the whole-cell voltage-clamp conﬁguration (holding potential,  60
mV) using an EPC-10 patch-clamp ampliﬁer and digitized at 2.9 kHz.
The extracellular solution consisted of 150 mM NaCl, 5 mM KCl, 5
mM CaCl2, 4 mM MgCl2, 10 mM glucose, 5 mM sucrose, and 15 mM
HEPES (pH 7.3, ;340 mOsm). The patch pipette was ﬁlled with 120
mM KCl, 20 mM KOH, 4 mM MgCl2, 5 mM (N-tris[Hydroxymethyl]
methyl-2-aminoethane-sulfonic acid), 0.25 mM CaCl2, 4 mM Na
2ATP,
36 mM sucrose, and 5 mM EGTA (pH 7.2, ;315 mOsm). Hyper-
osmotic data were recorded using an 800 mOsm extracellular
solution achieved through addition of sucrose. Data were acquired
using Pulse software (HEKA, Southboro, Massachusetts, United
States) run on a Dell computer. Subsequent analysis and graphing
was performed using Pulseﬁt (HEKA), Mini analysis (Synaptosoft Inc.,
Decatur, Georgia, United States) and Igor Pro (Wavemetrics, Lake
Oswego, Oregon, United States).
EM. N2, tom-1(ok285), tom-1(nu468), tom-1(ok285);unc-13(s69), unc-
13(s69), and TOM-1A rescue young-adult hermaphrodites were
prepared for high-pressure freezing as previously described [22].
Brieﬂy, ten to 15 animals were loaded in a specimen chamber ﬁlled
with E. coli and immobilized by high-pressure freezing at ;180 8C
under high pressure in a Bal-Tec HPM010 and moved to liquid
nitrogen.
Freeze substitution was performed in a Reichart AFS machine
(Leica, Oberkochen, Germany) as previously described [38] using
tannic acid (0.1%) and 0.5% gluteraldehyde ﬁxative introduced over
4 d followed by 2% osmium. Fixed animals were then washed and
embedded in Araldite 502 over a 48-h period at 60 8C.
Serial sections were cut at a thickness of 40–50 nm, collected on
formvar-covered carbon coated copper grids (EMS, FCF2010-Cu),
and counterstained in 2% or 2.5% aqueous uranyl acetate for 4 min,
followed by Reynolds lead citrate for 2 min. Images were obtained on
a JEOL JEM-1220 transmission electron microscope (JEOL, Tokyo,
Japan) operating at 80 kV. Micrographs were collected using a Gatan
digital camera (Pleasanton, California, United States).
Morphometric analysis of WT, tom-1(ok285), tom-1(nu468), tom-
1(ok285)unc-13(s69), unc-13(s69), and (jaIs1052) TOM-1A rescued
animals were performed from ventral nerve cord serial sections.
The analysis was performed blind. Images were quantiﬁed using NIH
Image software. A synapse was deﬁned as a set of serial sections
containing a presynaptic specialization and two ﬂanking sections
from both sides without presynaptic specialization. Several morpho-
metric measurements were obtained: the number of vesicles per
proﬁle, the distance from each vesicle membrane perpendicular to
the plasma membrane, and the distance to the proximal edge of the
presynaptic specialization.
Supporting Information
Figure S1. Coomassie Blue–Stained PAGE Gel of Mixed-Species
SNARE Complex Assembly Assays
Complex assays were performed using C. elegans His6-tagged SNAREs
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synaptobrevin were mixed, incubated to allow complex formation,
and separated on a PAGE gel to visualize complexes. One aliquot of
each sample was loaded without heating (rt), and the other was heated
to 95 8C for 5 min (b) prior to loading. The position of complexes,
syntaxin, SNAP-25, and C. elegans synaptobrevin (which migrates just
above the dye front) are labeled on the gel. Unfortunately, vertebrate
(v) synaptobrevin migrates in the dye front and is not identiﬁable on
the gel. Various combinations of C. elegans (c) and rat protein (v)
mixes were tried. All reactions containing puriﬁed C. elegans SNAP-25
failed to form complexes efﬁciently, while all other combinations
form complexes. The positions of molecular weight markers are on
the left.
Methods: C. elegans His6-tagged SNAREs and rat SNAP-25 were
puriﬁed as described in the main text. Rat His6-tagged synaptobrevin
and syntaxin were a gift from Michael Crowder (Washington
University School of Medicine) and puriﬁed as described in [39]. To
form complexes, puriﬁed syntaxin, SNAP-25, and synaptobrevin were
mixed, incubated overnight at 48 C, mixed with SDS-containing
sample buffer, and run on a 4%–12% PAGE gel.
Found at DOI: 10.1371/journal.pbio.0040261.sg001 (292 KB JPG).
Figure S2. C. elegans TOM-1Ct Does Not Form a Stable Binary
Complex with Syntaxin
A Coomassie-stained gel shows GST pull-down assays performed to
eliminate the possibility that TOM-1Ct forms a complex with
syntaxin in the absence of SNAP-25. C. elegans GST syntaxin or GST
alone was incubated with either rat SNAP-25 (vSNAP-25) or C. elegans
tomosyn C-terminal domain (TOM-1Ct). Glutathione agarose beads
were added to collect complexes. The supernatant was removed, and
the beads were washed extensively. Aliquots of the supernatant (sup)
and the protein eluted from the glutathione agarose (beads) were
separated on SDS-PAGE and stained for protein with Coomassie
Blue. Although syntaxin bound to SNAP-25 in the absence of TOM-
1Ct or synaptobrevin, TOM-1Ct did not interact with syntaxin in the
absence of SNAP-25. Molecular weights of markers are labeled on the
left.
Methods: proteins and GST pulled-down assays were performed as
described in the main text.
Found at DOI: 10.1371/journal.pbio.0040261.sg002 (543 KB JPG).
Figure S3. Enlarged Micrographs of Representative NMJ Used in the
Study
(A) WT. (B) tom-1(ok285). (C) tom-1(nu468) cholinergic synapse. (D)
Cholinergic synapse in jaIs1052 (an integrated array of TOM-1A
expressed in cholinergic neurons using the acr-2 promoter, in a tom-
1(nu468) mutant background). (E) tom-1(nu468) GABAergic synapse.
(F) GABAergic synapse in jaIs1052 (an integrated array of TOM-1A
expressed in cholinergic neurons using the acr-2 promoter, in a tom-
1(nu468) mutant background). (G) unc-13(s69). (H) tom-1(ok285) unc-
13(s69) double mutant. Arrows point to membrane-contacting
synaptic vesicles.
Found at DOI: 10.1371/journal.pbio.0040261.sg003 (2.8 MB JPG).
Accession Numbers
The Swiss-Prot/TrEMBL (http://www.ebi.ac.uk/swissprot; http://www.
ebi.ac.uk/embl) accession numbers for the following genes and gene
products are syntaxin-1a (O35526), SNAP-25 (P60879), synaptobre-
vin-2 (a.k.a. VAMP-2) (P63044), tomosyn (Q8K400), synaptotagmin
(P46096), Munc13 (Q9Z1N9), ROCK (P70335), Munc18
(Q548T0_MOUSE), tom-1 (Q49HI2_CAEEL), TOM-1B
(P91392_CAEEL), TOM-1A (P91389_CAEEL), TOM-1C
(Q8T3B2_CAEEL), synaptobrevin (SNB-1) (O02495_CAEEL), syn-
taxin (UNC-64) (O16000_CAEEL), SNAP-25 (RIC-4)
(O62414_CAEEL), and unc-13 (P27715).
Acknowledgments
We would like to thank Dr. Joshua Kaplan for supplying the TOM-1A
extrachromasomal array integrated in this study; Dr. Aixa Alfonso for
the UNC-17 antibody; Dr. Kenneth Miller and Dr. Jean-Louis
Bessereau for UNC-29 antibodies; Dr. Phyllis Hanson and Dr. C.
Michael Crowder for providing puriﬁed rat SNARE proteins; Dr.
Yishi Jin for supplying the cholinergic GFP reporter strain (juIs14);
Dr. Jean-Louis Bessereau (INSERM), Linda Juarez and Kristina
Jarosius (RRC EM facility at UIC), and Jay Campbell with the LOCI
lab at UW-Madison for technical assistance with the high-pressure
freeze EM; and Dr. Robert Wykes and Dr. David Featherstone for
constructive criticism of the manuscript.
Author contributions. EOG, AOB, AMH, MLN, RMW, and JER
conceived and designed the experiments. EOG, AOB, AMH, MBG,
JER, BDA, GH, and MLN performed the experiments. EOG, AOB,
AMH, BDA, and MLN analyzed the data. MLN and RMW contributed
reagents/materials/analysis tools. EOG, JER, and RMW wrote the
paper.
Competing interests. The authors have declared that no competing
interests exist.
Funding. Funding for this study was provided by National
Institutes of Health (NIH) RO1 NS41477 to JER and NIH R01
NS35335 to MLN and MDA3930 to BDA.
References
1. Ferro-Novick S, Jahn R (1994) Vesicle fusion from yeast to man. Nature 370:
191–193.
2. Rothman JE (1994) Mechanisms of intracellular protein transport. Nature
372: 55–63.
3. Fasshauer D, Sutton RB, Brunger AT, Jahn R (1998) Conserved structural
features of the synaptic fusion complex: SNARE proteins reclassiﬁed as Q-
and R-SNAREs. Proc Natl Acad Sci U S A 95: 15781–15786.
4. Sutton RB, Fasshauer D, Jahn R, Brunger AT (1998) Crystal structure of a
SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature
395: 347–353.
5. Hanson PI, Roth R, Morisaki H, Jahn R, Heuser JE (1997) Structure and
conformational changes in NSF and its membrane receptor complexes
visualized by quick-freeze/deep-etch electron microscopy. Cell 90: 523–535.
6. Fujita Y, Shirataki H, Sakisaka T, Asakura T, Ohya T, et al. (1998) Tomosyn:
A syntaxin-1-binding protein that forms a novel complex in the neuro-
transmitter release process. Neuron 20: 905–915.
7. Yokoyama S, Shirataki H, Sakisaka T, Takai Y (1999) Three splicing variants
of tomosyn and identiﬁcation of their syntaxin-binding region. Biochem
Biophys Res Commun 256: 218–222.
8. Groffen AJ, Jacobsen L, Schut D, Verhage M (2005) Two distinct genes drive
expression of seven tomosyn isoforms in the mammalian brain, sharing a
conserved structure with a unique variable domain. J Neurochem 92: 554–
568.
9. Masuda ES, Huang BC, Fisher JM, Luo Y, Scheller RH (1998) Tomosyn binds
t-SNARE proteins via a VAMP-like coiled coil. Neuron 21: 479–480.
10. Hatsuzawa K, Lang T, Fasshauer D, Bruns D, Jahn R (2003) The R-SNARE
motif of tomosyn forms SNARE core complexes with syntaxin 1 and SNAP-
25 and down-regulates exocytosis. J Biol Chem 278: 31159–31166.
11. Pobbati A, Razeto A, Boddener M, Becker S, Fasshauer D (2004) Structural
basis for the inhibitory role of tomosyn in exocytosis. J Biol Chem. 279:
47192–47200.
12. Yizhar O, Matti U, Melamed R, Hagalili Y, Bruns D, et al. (2004) Tomosyn
inhibits priming of large dense-core vesicles in a calcium-dependent
manner. Proc Natl Acad Sci U S A 101: 2578–2583.
13. Widberg CH, Bryant NJ, Girotti M, Rea S, James DE (2003) Tomosyn
interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in
insulin-stimulated GLUT4 translocation. J Biol Chem 278: 35093–35101.
14. Zhang W, Lilja L, Mandic SA, Gromada J, Smidt K, et al. (2006) Tomosyn is
expressed in beta-cells and negatively regulates insulin exocytosis. Diabetes
55: 574–581.
15. Baba T, Sakisaka T, Mochida S, Takai Y (2005) PKA-catalyzed phosphor-
ylation of tomosyn and its implication in Ca2þ-dependent exocytosis of
neurotransmitter. J Cell Biol 170: 1113–1125.
16. Dybbs M, Ngai J, Kaplan JM (2005) Using microarrays to facilitate positional
cloning: Identiﬁcation of tomosyn as an inhibitor of neurosecretion. PLoS
Genet 1: 6–16.
17. Saifee O, Wei L, Nonet ML (1998) The Caenorhabditis elegans unc-64 locus
encodes a syntaxin that interacts genetically with synaptobrevin. Mol Biol
Cell 9: 1235–1252.
18. Staunton J, Ganetzky B, Nonet ML (2001) Rabphilin potentiates soluble N-
ethylmaleimide sensitive factor attachment protein receptor function
independently of rab3. J Neurosci 21: 9255–9264.
19. Sakisaka T, Baba T, Tanaka S, Izumi G, Yasumi M, et al. (2004) Regulation of
SNAREs by tomosyn and ROCK: Implication in extension and retraction of
neurites. J Cell Biol 166: 17–25.
20. Hallam S, Singer E, Waring D, Jin Y (2000) The C. elegans NeuroD homolog
cnd-1 functions in multiple aspects of motor neuron fate speciﬁcation.
Development 127: 4239–4252.
21. Alfonso A, Grundahl K, Duerr JS, Han HP, Rand JB (1993) The
Caenorhabditis elegans unc-17 gene: A putative vesicular acetylcholine trans-
porter. Science 261: 617–619.
22. Rostaing P, Weimer RM, Jorgensen EM, Triller A, Bessereau JL (2004)
Preservation of immunoreactivity and ﬁne structure of adult C. elegans
tissues using high-pressure freezing. J Histochem Cytochem 52: 1–12.
PLoS Biology | www.plosbiology.org August 2006 | Volume 4 | Issue 8 | e261 1436
Tomosyn Inhibits Vesicle Priming23. Chen YA, Scales SJ, Scheller RH (2001) Sequential SNARE assembly
underlies priming and triggering of exocytosis. Neuron 30: 161–170.
24. Augustin I, Rosenmund C, Sudhof TC, Brose N (1999) Munc13–1 is essential
for fusion competence of glutamatergic synaptic vesicles. Nature 400: 457–
461.
25. Richmond JE, Davis WS, Jorgensen EM (1999) UNC-13 is required for
synaptic vesicle fusion in C. elegans. Nat Neurosci 2: 959–964.
26. Aravamudan B, Fergestad T, Davis WS, Rodesch CK, Broadie K (1999)
Drosophila UNC-13 is essential for synaptic transmission. Nat Neurosci 2:
965–971.
27. Betz A, Okamoto M, Benseler F, Brose N (1997) Direct interaction of the rat
unc-13 homologue Munc13–1 with the N terminus of syntaxin. J Biol Chem
272: 2520–2526.
28. Dulubova I, Sugita S, Hill S, Hosaka M, Fernandez I, et al. (1999) A
conformational switch in syntaxin during exocytosis: role of munc18.
EMBO J 18: 4372–4382.
29. Richmond JE, Weimer RM, Jorgensen EM (2001) An open form of syntaxin
bypasses the requirement for UNC-13 in vesicle priming. Nature 412: 338–
341.
30. Madison JM, Nurrish S, Kaplan JM (2005) UNC-13 interaction with syntaxin
is required for synaptic transmission. Curr Biol 15: 2236–2242.
31. Stevens DR, Wu ZX, Matti U, Junge HJ, Schirra C, et al. (2005) Identiﬁcation
of the minimal protein domain required for priming activity of Munc13–1.
Curr Biol 15: 2243–2248.
32. Basu J, Shen N, Dulubova I, Lu J, Guan R, et al. (2005) A minimal domain
responsible for Munc13 activity. Nat Struct Mol Biol 12: 1017–1018.
33. Robitaille R, Adler EM, Charlton MP (1990) Strategic location of calcium
channels at transmitter release sites of frog neuromuscular synapses.
Neuron 5: 773–779.
34. Foletti DL, Lin R, Finley MA, Scheller RH (2000) Phosphorylated syntaxin 1
is localized to discrete domains along a subset of axons. J Neurosci 20:
4535–4544.
35. Margittai M, Otto H, Jahn R (1999) A stable interaction between syntaxin 1a
and synaptobrevin 2 mediated by their transmembrane domains. FEBS Lett
446: 40–44.
36. Frangioni JV, Neel BG (1993) Solubilization and puriﬁcation of enzymati-
cally active glutathione S-transferase (pGEX) fusion proteins. Anal
Biochem 210: 179–187.
37. Charlie NK, Schade MA, Thomure AM, Miller KG (2006) Presynaptic UNC-
31 (CAPS) is required to activate the G (alpha)s pathway of the synaptic
signaling network. Genetics. 172: 943–961.
38. Weimer RM. Preservation of C. elegans tissue via high-pressure freezing and
freeze-substitution for ultrastructural analysis and immuno-cytochemistry.
In: Strange K, editor. C elegans: Methods and applications. Totowa, NJ:
Humana Press. In press.
39. Nagele P, Mendel JB, Placzek WJ, Scott BA, D’Avignon DA, et al. (2005)
Volatile anesthetics bind rat synaptic snare proteins. Anesthesiology 103:
768–778.
PLoS Biology | www.plosbiology.org August 2006 | Volume 4 | Issue 8 | e261 1437
Tomosyn Inhibits Vesicle Priming